Spectrascience Inc (SCIE) Financial Statements (2025 and earlier)

Company Profile

Business Address 11568 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. MN
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 412722423790
Cash and cash equivalent 412722423790
Receivables 17 60 
Inventory, net of allowances, customer advances and progress billings 91112284247202
Inventory 91112284247202
Deferred costs  8010882166
Prepaid expense and other current assets191
Other undisclosed current assets 267284244175 
Total current assets: 362611859801649
Noncurrent Assets
Inventory, Noncurrent  150   
Property, plant and equipment  041686
Intangible assets, net (including goodwill) 1,0251,1851,3481,5131,679
Intangible assets, net (excluding goodwill) 1,0251,1851,3481,5131,679
Total noncurrent assets: 1,0251,3361,3521,5291,764
TOTAL ASSETS: 1,3861,9472,2112,3302,413
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,5972,3521,5091,4401,046
Accounts payable 1,3199418361,009862
Accrued liabilities 2,2781,411673431184
Debt 6,3505,8253,9202,337609
Derivative instruments and hedges, liabilities 8206201,0621,1042,336
Due to related parties 35    
Other undisclosed current liabilities  138100  
Total current liabilities: 10,8028,9366,5914,8823,990
Noncurrent Liabilities
Long-term debt and lease obligation 1,100 4,4972,952 
Long-term debt, excluding current maturities 1,100 4,4972,952 
Liabilities, other than long-term debt     1,730
Derivative instruments and hedges, liabilities     1,730
Total noncurrent liabilities: 1,100 4,4972,9521,730
Total liabilities: 11,9028,93611,0887,8335,720
Equity
Equity, attributable to parent, including: (10,546)(7,020)(4,381)(2,551)(1,576)
Common stock 8,8374,3121,9441,6671,522
Additional paid in capital 34,58338,16739,50937,12735,492
Retained earnings (accumulated deficit) (53,966)(49,499)(45,864)(41,376)38,626
Other undisclosed equity, attributable to parent 0 3131(77,216)
Total equity: (10,546)(7,020)(4,381)(2,551)(1,576)
Other undisclosed liabilities and equity 3131(4,497)(2,952)(1,730)
TOTAL LIABILITIES AND EQUITY: 1,3861,9472,2112,3302,413

Income Statement (P&L) ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 57 240461
Cost of revenue (199)(1) (125)(313)
Other undisclosed gross profit   8  
Gross profit: (194)68115148
Operating expenses (2,250)(2,489)(2,714)(2,846)(4,469)
Operating loss: (2,444)(2,483)(2,706)(2,732)(4,321)
Nonoperating expense (2,022)(1,151)(1,783)(18)(4,772)
Investment income, nonoperating     2,230
Other nonoperating expense (1)(13)(22)(10)(1)
Interest and debt expense 470261(197)(69)(2,381)
Loss from continuing operations: (3,997)(3,374)(4,686)(2,819)(11,474)
Loss before gain (loss) on sale of properties: (3,997)(3,374)(4,686)(2,819)(11,474)
Other undisclosed net income   197692,381
Net loss: (3,997)(3,374)(4,488)(2,750)(9,093)
Other undisclosed net loss attributable to parent (470)(261)   
Net loss attributable to parent: (4,467)(3,635)(4,488)(2,750)(9,093)
Other undisclosed net income available to common stockholders, basic     18,185
Net income (loss) available to common stockholders, basic: (4,467)(3,635)(4,488)(2,750)9,093
Dilutive securities, effect on basic earnings per share     13,516
Other undisclosed net loss available to common stockholders, diluted     (11,285)
Net income (loss) available to common stockholders, diluted: (4,467)(3,635)(4,488)(2,750)11,323

Comprehensive Income ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (3,997)(3,374)(4,488)(2,750)(9,093)
Comprehensive loss, net of tax, attributable to parent: (3,997)(3,374)(4,488)(2,750)(9,093)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: